Evidence-based Pain Management: Addressing the Growing Role of Nurse Practitioners and Physician Assistants in Managing Patients with Acute and Chronic Pain
- CME / AMA PRA Category 1 Credit™
DATES AND TIMES
Tuesday, June 16, 2020
4:00 – 7:00 PM ET (3:00 – 6:00 PM CST / 1:00 – 4:00 PM PST)
Program Faculty: Christopher Gharibo, MD; Susan Pendergrass, MSN, MEd, APRN, FNP-BC
Wednesday, July 15, 2020
6:00 – 9:00 PM ET (5:00 – 8:00 PM CST / 3:00 – 6:00 PM PST)
Program Faculty: Jeremy A. Adler, DMSc, PA-C; Christopher Gharibo, MD
Primary care providers (PCPs) are responsible for almost half of all opioid prescriptions written in the US, and a recent study found that primary care NPs and PAs wrote more opioid prescriptions than their physician colleagues. However, limited time, training, and access to resources often make it difficult for these clinicians to effectively evaluate their patients presenting with pain and choose a treatment that best fits each patient’s needs.
This CME activity, Evidence-based Pain Management: Addressing the Growing Role of Nurse Practitioners and Physician Assistants in Managing Patients with Acute and Chronic Pain, will help community NPs and PAs use pain-assessment tools to evaluate patients, improve their familiarity with the FDA Blueprint guidelines for treatment selection, and understand when to use non-opioid pharmacotherapies for neuropathic pain.
Welcome and Introduction
The need for pain education
Mechanisms of pain and definitions
Assessment and risk stratification of patient in pain
Components of an effective treatment plan
Non-pharmacologic, pharmacologic and alternative therapeutic options for pain
Managing patients on opioid analgesics
Assessing risk of and management of opioid use disorder
Q&A and Concluding Remarks
This activity is intended for is clinicians involved in direct patient care, including HCPs who are registered with the DEA and eligible to prescribe all opioid analgesics. In addition, because of the broad scope of the revised FDA blueprint, the intended audience may include members of the healthcare team without authorization to prescribe.
Specifically, this education will be targeted to NPs and PAs who need to improve their ability to obtain a balance between optimal pain reduction and minimization of adverse events (e.g. abuse, addiction, side effects, and risk of workplace accidents).
At the conclusion of this activity, participants should be able to:
- Incorporate tools to assist in assessing pain, stratifying risks
- Evaluate components of effective treatment plan: acute vs chronic pain, treatment goals, multimodal strategies
- Make evidence-based treatment plan recommendations: non-/pharmacologic and alternative therapies
- When considering opioid therapy, assess potential for abuse and evidence-based monitoring
- Discuss evidence-based options for opioid use disorder: physician-patient counseling, local/national/online resources
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and Rockpointe. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please email: firstname.lastname@example.org.
Pain Management PA/COO
Pacific Pain Medicine Consultants
Medical Director of Pain Medicine
NYU Langone Health
Associate Professor of Anesthesiology, Pain Medicine and Orthopedics
New York, NY
Independent Pain Consultant
Fernandina Beach, FL
Senior Director of Training and TA for Substance Use
National Council for Behavioral Health
AANP DESIGNATION STATEMENT
AMERICAN ASSOCIATION OF PHYSICIAN ASSISSTANTS (AAPA) CREDIT DESIGNATION
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 3 AAPA Category 1 CME credits. Approval is valid from 6/15/2020 to 6/15/2021 . PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200578.
A conflict of interest is created when individuals in a position to control the content of an accredited educational activity have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks, or other financial benefits. USF Health will identify, review, and resolve all conflicts of interest that speakers, authors, or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Faculty and Steering Committee Disclosures
The faculty and steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Jeremy Adler, DMSc, PA-C: Advisory Board: BioDelivery Sciences International, US WorldMeds; Speaker’s Bureau: BioDelivery Sciences International, Daiichi Sankyo, Pfizer, Scilex
Christopher Gharibo, MD: Consultant: Averitas, DSI, Persion, Salix; Speaker’s Bureau: Scilex
Susan Pendergrass, MSN, Med, APRN, FNP-BC: Advisory Board: Johnson & Johnson, Pear Therapeutics; Consultant/Speaker’s Bureau: Johnson & Johnson
Aaron Williams, MA: Nothing to disclose
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Martin Myers, MD: Advisory Board: Amgen
Chad Williamson, MS, MBA, CMMP; USF Health CPD staff: Nothing to disclose
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME/CE CREDIT
If you will be watching the webinar in a group setting, please note all group participants will need to register individually in order to complete the post-test and evaluation to receive credit.
Jointly provided by USF Health and Rockpointe
In collaboration with
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see
https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
Breakthroughs with NASH Management: What Do Gastroenterologists and Hepatologists Need to Know?
Credits 1.00 (60 min)
Management of Neovascular Age-Related Macular Degeneration: Improving Patient Outcomes
Credits 1.00 (60 min)
Eosinophilic Granulomatosis with Polyangiitis: Where Are We with Diagnosis and Management?
Credits 1.00 (60 min)